4 completed. 2 Phase 4, 1 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Prof. Stephen Lee: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| EGO-COMBO Angiographic Extension Study The COMBO Stent - Coronary Disease | Not applicable | Completed | Prof. Stephen Lee | 41 | 2012-12-01 | 2014-10-23 |
| OCT Evaluation of Healing of COMBO Stent COMBO Stent (OrbusNeich Medical, Fort Lauderdale, Florida) - Coronary Restenosis, Coronary Thrombosis | Phase 1 / Phase 2 | Completed | Prof. Stephen Lee | 61 | 2010-10-01 | 2013-02-28 |
| OCT Evaluation of Early Healing of EPC Capturing (GENOUS) Stent (EGO Study) Coronary Intervention (GENOUS stent) - Coronary Artery Disease | Phase 4 | Completed | Prof. Stephen Lee | 53 | 2010-06-01 | 2013-02-28 |
| Virtual Histology Findings and Effects of Varying Doses of Atorvastatin Treatment Atorvastatin 10mg versus 40mg. - Coronary Disease, Ultrasonography, Interventional | Phase 4 | Completed | Prof. Stephen Lee | 40 | 2007-08-01 | 2013-02-28 |
Coronary Disease (2) · Coronary Artery Disease (1) · Coronary Restenosis (1) · Coronary Thrombosis (1) · Hyperplasia (1)
Atorvastatin (1)
China (2) · Hong Kong (2)
Stephen WL Lee, MD FRCP FACC (2) · Stephen Lee, MD FRCP FACC (1)
PMID 15893169, PMID 18082503, PMID 18307999, PMID 18360849, PMID 19737719, PMID 27418609, PMID 20442358